Last 112.45 INR
Change Today -0.95 / -0.84%
Volume 97.5K
ELDP On Other Exchanges
Symbol
Exchange
Natl India
As of 6:05 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

elder pharmaceuticals ltd (ELDP) Snapshot

Open
115.50
Previous Close
113.40
Day High
115.50
Day Low
111.65
52 Week High
12/20/13 - 278.35
52 Week Low
12/16/14 - 105.10
Market Cap
2.3B
Average Volume 10 Days
185.7K
EPS TTM
1.33
Shares Outstanding
20.5M
EX-Date
09/17/12
P/E TM
84.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for ELDER PHARMACEUTICALS LTD (ELDP)

Related News

No related news articles were found.

elder pharmaceuticals ltd (ELDP) Related Businessweek News

No Related Businessweek News Found

elder pharmaceuticals ltd (ELDP) Details

Elder Pharmaceuticals Limited manufactures and markets prescription pharmaceutical products, and surgical and medical devices in India and internationally. The company offers various products in the therapeutic areas of women’s health, wound care and pain management, nutraceuticals/vitamin supplements, lifestyle diseases care, diabetics, antibiotics, and anti-infective. It provides its products in various dosage forms, such as tablets, capsules, syrups, injectables, skin creams, and ointments. The company also offers medical equipment, such as oxygen concentrators and nebulisers; and industrial equipment for instrumentation and weighing based automation applications. Further, the company markets healthcare products. Elder Pharmaceuticals Limited was incorporated in 1983 and is based in Mumbai, India.

Founded in 1983

elder pharmaceuticals ltd (ELDP) Top Compensated Officers

Chief Executive Officer, Managing Director, W...
Total Annual Compensation: 7.4M
Compensation as of Fiscal Year 2013.

elder pharmaceuticals ltd (ELDP) Key Developments

Saleem Shervni Tenders Resignation as Non-Executive - Independent Director of Elder Pharmaceuticals

Elder Pharmaceuticals informed that Saleem Shervni, Non-Executive - Independent Director of the company has tendered his resignation as Non-Executive - Independent Director of the company with effect from December 11, 2014.

Elder Pharmaceuticals Appoints Bimal Desai as Chief Financial Officer

Elder Pharmaceuticals has informed that as per Listing Agreement and Section 203 of the Companies Act 2013 read with the Companies (Appointment Remuneration of Managerial Personnel) Rules, 2014, Bimal Desai is been appointed as Chief Financial Officer (CFO) of the Company with effect from December 01, 2014.

Elder Pharmaceuticals Ltd Resignation of Urvashi Saxena as Non-Executive Independent Director

Elder Pharmaceuticals Ltd. announced that Mrs. Urvashi Saxena, Non-Executive Independent Director has tendered her resignation as Director of the Company with effect from November 28, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ELDP:IN 112.45 INR -0.95

ELDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $46.05 USD +0.28
Cadila Healthcare Ltd 1,514 INR -21.60
Cipla Ltd/India 618.95 INR -6.40
GlaxoSmithKline PLC 1,392 GBp +13.50
View Industry Companies
 

Industry Analysis

ELDP

Industry Average

Valuation ELDP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELDER PHARMACEUTICALS LTD, please visit www.elderindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.